1. Brand medications and Medicare Part D: how eye care providers’ prescribing patterns influence costs;Newman-Casey;Ophthalmology,2018
2. A systematic evaluation of state laws governing optometric glaucoma management in the United States upto 2015;Chodnicki;J Glaucoma,2018
3. The effects of state-level pharmacist regulations on generic substitution of prescription drugs;Song;Health Econ,2018
4. United States Food & Drug Administration. Product details for ANDA 091340. In: Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations. Available at: https://www.accessdata.fda.gov/scripts/cder/ob/results_product.cfm?Appl_Type=A&Appl_No=091340; Accessed October 2, 2018.
5. United States Food & Drug Administration. Product details for ANDA 203991. In: Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations. Available at: https://www.accessdata.fda.gov/scripts/cder/ob/results_product.cfm?Appl_Type=A&Appl_No=203991; Accessed October 2, 2018.